Suppr超能文献

血管紧张素II AT1受体的缬氨酸254、组氨酸256和苯丙氨酸259残基不参与配体结合,但参与信号转导。

Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction.

作者信息

Han H M, Shimuta S I, Kanashiro C A, Oliveira L, Han S W, Paiva A C

机构信息

Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo, Brazil.

出版信息

Mol Endocrinol. 1998 Jun;12(6):810-4. doi: 10.1210/mend.12.6.0127.

Abstract

The role of the external third of helix VI of the angiotensin II (AII) AT1 receptor for the interaction with its ligand and for the subsequent signal transduction was investigated by individually replacing residues 252-256 by Ala, and residues 259 or 261 by Tyr, and permanently transfecting the resulting mutants to Chinese hamster ovary (CHO) cells. Binding experiments showed no great changes in affinity of any of the mutants for AII, [Sar1]-AII, or [Sar1, Leu8]-AII, but the affinity for the nonpeptide antagonist DuP753 was significantly decreased. The inositol phosphate response to AII was remarkably decreased in mutants V254A, H256A, and F259Y. These results indicate that AT1 residues Val254, His256, and Phe259 are not involved in ligand binding but participate in signal transduction. Based in these results and in others from the literature, it is suggested that, in addition to the His256 imidazole ring, the Phe259 aromatic ring interacts with the AII's Phe8, thus contributing to the signal-triggering mechanism.

摘要

通过将血管紧张素 II(AII)AT1 受体螺旋 VI 外部三分之一区域的 252 - 256 位残基逐个替换为丙氨酸,以及将 259 或 261 位残基替换为酪氨酸,并将所得突变体永久转染至中国仓鼠卵巢(CHO)细胞,研究了该区域对于与配体相互作用及后续信号转导的作用。结合实验表明,任何一个突变体对 AII、[Sar1]-AII 或 [Sar1, Leu8]-AII 的亲和力均无显著变化,但对非肽拮抗剂 DuP753 的亲和力显著降低。在突变体 V254A、H256A 和 F259Y 中,对 AII 的肌醇磷酸反应显著降低。这些结果表明,AT1 受体的 Val254、His256 和 Phe259 残基不参与配体结合,但参与信号转导。基于这些结果以及文献中的其他结果,有人提出,除了 His256 的咪唑环外,Phe259 的芳香环与 AII 的 Phe8 相互作用,从而有助于信号触发机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验